Valiant Organics Limited

BSE: 540145 NSE: VALIANTORG
Valiant Organics Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L24230MH2005PLC151348 Incorporated 16 February 2005 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: VALIANTORG · BSE: 540145 Public Limited Company chemicals and materials
Data last updated
Market Cap
₹1,221 Cr
VALIANTORG · NSE
Share Price
₹418.20
-3.96% today
Revenue
₹739 Cr
FY 2025-26 · +2.8% YoY
EBITDA
₹87.06 Cr
Margin 11.8%
Net Profit
₹25.98 Cr
FY 2025-26 · +400.0% YoY
P/E (TTM)
25.3x
P/B 1.7x
ROE
3.5%
ROCE 5.4%
Debt / Equity
0.34
Interest cover 38.3x

About Valiant Organics Limited

Data last updated:

Valiant Organics Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 16 February 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24230MH2005PLC151348. Its GSTIN is 27AACCV0024A2Z2 (Maharashtra). The company holds 5 GST registrations, of which 3 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 540145 and NSE: VALIANTORG.

The company has an authorised share capital of ₹55 Cr and a paid-up capital of ₹28.03 Cr. It was formerly known as Valiant Organics Private Limited. It is led by directors including Sathiababu Krishnan Kallada (Managing Director) and Parimal Hasmukhlal Desai (Managing Director).

Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 109 Udyog Kshetra 1st Floor Mulund Goregaon Link Road Mulund (W), Mumbai, Maharashtra, India – 400080.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹738.76 Cr, a growth of 2.8% compared to the previous year. For the same year it recorded a net profit of ₹25.98 Cr (net margin 3.5%) and EBITDA of ₹87.06 Cr (EBITDA margin 11.8%). The net worth stands at ₹759.38 Cr (up 4.7% YoY). Total assets are valued at ₹1,035.53 Cr (up 5.9% YoY).

The company has about 968 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.

The company is associated with 1 brand: Valiant Organics. As per MCA filings, the company has open charges of ₹447.5 Cr and satisfied charges of ₹294.31 Cr on record. Court records list 10 cases involving the company, including 3 filed by the company and 7 filed against it; 1 case is pending. The company has 27 deals on record (13 market trades, 9 secondary share transfers, 4 funding rounds), with disclosed funding of ₹10.82 Cr; the latest was in March 2026. Its 7 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Gramercy Trade Industries Private Limited with revenue of ₹767.72 Cr. The company has 4 MSME Form 1 returns on record between 2023 and 2024, listing 434 overdue payments to 127 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website valiantorganics.com.

Company details

CIN L24230MH2005PLC151348
Registration Number 151348
Incorporation Date 16 February 2005
ROC Mumbai
Listing Status Listed - Listed on NSE (VALIANTORG); Listed on BSE (540145)
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant

CIN history

Valiant Organics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24230MH2005PLC151348, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24230MH2005PLC151348Current
U24230MH2005PTC151348Previous
U24230MH2005PLC151348Previous
Key People
Sathiababu Krishnan Kallada Managing Director Parimal Hasmukhlal Desai Managing Director Mahek Manoj Chheda Whole-Time Director

Contact details

Valiant Organics Limited's registered office is in Mumbai, Maharashtra. Its website is valiantorganics.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    valiantorganics.com
  • Registered Address
    109 Udyog Kshetra 1st Floor Mulund Goregaon Link Road Mulund (W), Mumbai, Maharashtra, India – 400080
  • Industry
    Chemicals and Materials, Specialty Chemicals

To see the full contact details of Valiant Organics Limited, buy the company report.

Comprehensive company report
Valiant Organics Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Valiant Organics operates one associated brand: Valiant Organics. Each brand links to its own profile.

BrandDescriptionWebsite
Valiant Organics
Manufacturer and supplier of diversified chemicalsvaliantorganics.com

Business activity

The main business activity of Valiant Organics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Valiant Organics Limited, buy the company report.

Financials of Valiant Organics Limited

FY 2025-26 filings available

Valiant Organics Limited reported revenue of ₹738.76 Cr (up 2.8% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹739 Cr
+2.8% YoY
EBITDA
₹87.06 Cr
+63.7% YoY
Profit After Tax
₹25.98 Cr
+400.0% YoY
Net Worth
₹759 Cr
+4.7% YoY
Total Assets
₹1,036 Cr
+5.9% YoY
Total Debt
₹256 Cr
+2.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue7397197231,0521,153755675
Revenue growth+2.8%-0.6%-31.3%-8.8%+52.8%+11.8%-
EBITDA87.0653.1833.26164205205181
EBITDA margin+11.8%+7.4%+4.6%+15.6%+17.8%+27.2%+26.7%
Profit before tax41.932.15(8.70)137176185168
Net profit25.98(8.66)(6.44)84.37113115124
Net profit margin+3.5%-1.2%-0.9%+8.0%+9.8%+15.2%+18.4%
EPS (₹)11.86(1.33)(3.04)32.4541.7242.19102.00
Balance sheet
Total assets1,0369789901,0151,013718539
Net worth759725729689613502388
Total debt256249257274363209138
Cash & bank2.147.653.808.1545.3830.9812.68
Net working capital203185180243370161105
Cash flow
Cash from operations91.9956.4384.00238(30.75)113161
Cash from investing(86.22)(20.96)(65.19)(143)(124)(156)(184)
Cash from financing(11.07)(31.81)(23.12)(112)16748.6427.16
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue232218159157204204187160
Revenue growth (YoY)+13.3%+6.9%-14.8%-1.8%+21.7%---
Other income10.514.627.360.271.700.915.852.53
EBITDA41.6226.4913.2121.1624.8720.6915.320.74
EBITDA margin+18.0%+12.2%+8.3%+13.5%+12.2%+10.2%+8.2%+0.5%
Depreciation10.2210.2510.119.789.429.208.998.79
Interest5.133.304.604.216.055.075.838.25
Profit before tax36.7817.565.867.4411.107.336.35(13.77)
Tax7.511.832.201.762.903.140.89(1.30)
Net profit29.2715.733.665.688.204.195.46(12.47)
EPS (₹)10.445.611.302.022.931.521.01(4.45)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue738719677912948574584
Revenue growth+2.7%+6.1%-25.7%-3.9%+65.2%-1.6%-
EBITDA88.2053.9739.54130167157174
EBITDA margin+12.0%+7.5%+5.8%+14.3%+17.6%+27.4%+29.8%
Profit before tax43.072.41(5.13)99.64137152165
Net profit27.17(5.76)(7.58)71.88101115124
Net profit margin+3.7%-0.8%-1.1%+7.9%+10.7%+20.0%+21.2%
EPS (₹)12.26(1.07)(1.10)27.8337.9142.20102.00
Balance sheet
Total assets936877884887909653505
Net worth697662665666603502388
Total debt219212216220305149117
Cash & bank1.637.433.576.5823.3011.7810.58
Net working capital20213613117725792.7979.47
Cash flow
Cash from operations44.2958.5685.09183(11.17)115160
Cash from investing(38.90)(27.06)(65.03)(90.63)(120)(135)(191)
Cash from financing(11.17)(27.65)(23.12)(109)14621.8935.43
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue232218159157204204187160
Revenue growth (YoY)+13.3%+6.8%-14.9%-1.9%+21.7%---
Other income2.644.017.360.201.070.675.042.02
Total expenses190191143136180183172158
EBITDA41.6326.4915.6221.1624.8820.7115.332.37
EBITDA margin+18.0%+12.2%+9.8%+13.5%+12.2%+10.2%+8.2%+1.5%
Depreciation10.2210.2510.119.789.429.208.998.79
Interest5.133.304.604.216.055.075.838.25
Profit before tax28.9216.958.277.3710.487.115.55(12.65)
Tax7.091.832.201.762.903.150.91(1.50)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 31 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue232218159157204204187160
Revenue growth (YoY)+13.3%+6.9%-14.8%-1.8%+21.7%---
Other income10.514.627.360.271.700.915.852.53
EBITDA41.6226.4913.2121.1624.8720.6915.320.74
EBITDA margin+18.0%+12.2%+8.3%+13.5%+12.2%+10.2%+8.2%+0.5%
Depreciation10.2210.2510.119.789.429.208.998.79
Interest5.133.304.604.216.055.075.838.25
Profit before tax36.7817.565.867.4411.107.336.35(13.77)
Tax7.511.832.201.762.903.140.89(1.30)
Net profit29.2715.733.665.688.204.195.46(12.47)
EPS (₹)10.445.611.302.022.931.521.01(4.45)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue7397197231,0521,153755675
Revenue growth+2.8%-0.6%-31.3%-8.8%+52.8%+11.8%-
Other income12.648.789.3012.937.425.946.30
Total expenses652666690888948549494
Employee cost48.8644.9949.3546.3337.1629.4022.78
EBITDA87.0653.1833.26164205205181
EBITDA margin+11.8%+7.4%+4.6%+15.6%+17.8%+27.2%+26.7%
Depreciation39.5735.7634.9229.1929.6221.2415.77
Interest18.2024.0516.3410.796.485.202.57
Profit before tax41.932.15(8.70)137176185168
Tax8.715.58(0.29)34.6148.2653.9942.29
Net profit25.98(8.66)(6.44)84.37113115124
Net profit margin+3.5%-1.2%-0.9%+8.0%+9.8%+15.2%+18.4%
EPS (₹)11.86(1.33)(3.04)32.4541.7242.19102.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital28.0228.0027.5827.5627.5627.5613.98
Reserves & surplus731697702662586475374
Shareholders' funds (net worth)759725729689613502388
Minority interest(0.01)0.000.0050.8935.756.3013.13
Secured loans185190180219308126105
Unsecured loans71.0458.8676.7754.8955.7982.8133.01
Total debt256249257274363209138
Total liabilities1,0369789901,0151,013718539
Assets
Gross block925847800815656625371
Net block695657643670543510276
Capital work in progress21.1665.7086.1470.8811245.89129
Investments15193.5898.6041.197.816.3422.85
Inventories92.6288.9711412611472.1744.86
Sundry debtors243177209254321157133
Cash & bank balances2.147.653.808.1545.3830.9812.68
Loans & advances15.2582.5681.9844.8542.4038.8529.15
Total current assets353356409434522299219
Total current liabilities151171229191152137115
Net working capital203185180243370161105
Total assets1,0369789901,0151,013718539
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash7.103.447.7525.0512.837.662.86
Net cash from operating activities91.9956.4384.00238(30.75)113161
Net cash from investing activities(86.22)(20.96)(65.19)(143)(124)(156)(184)
Net cash from financing activities(11.07)(31.81)(23.12)(112)16748.6427.16
Net change in cash(5.30)3.66(4.31)(17.30)12.215.184.80
Closing cash2.147.653.808.1545.3830.9812.68
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+2.8%-0.6%-31.3%-8.8%+52.8%+11.8%-
EBITDA growth+63.7%+59.9%-79.8%-19.8%-0.3%+13.8%-
PBT growth+1850.2%+9998.0%--22.1%-4.7%+9.7%-1.6%
Net income growth+400.0%-34.5%-107.6%-25.5%-1.1%-7.6%-
Revenue CAGR (3Y)-11.1%-14.6%-1.4%+15.9%+18.5%--
EBITDA CAGR (3Y)-19.1%-36.2%-45.5%-3.1%+4.4%--
Profitability & leverage
Net income margin+4.5%-0.5%-1.2%+9.8%+11.1%+17.3%+18.7%
Return on capital employed+5.4%+2.5%+1.1%+15.2%+21.6%+30.7%+39.5%
Return on net worth+3.5%-1.2%-0.9%+15.8%+23.0%+29.5%+39.1%
Debt / equity0.340.350.370.490.510.390.33
Long-term debt / equity0.070.090.100.140.160.180.20
Interest cover38.32138.06-984.347.993.702.821.56
Efficiency & per share
Fixed asset turnover0.830.870.901.431.831.512.25
Inventory turnover8.147.076.018.7712.4112.9014.55
Debtors turnover3.523.723.123.664.835.224.93
EPS (₹)11.86(1.33)(3.04)32.4541.7242.19102.00
Dividend per share (₹)0.000.000.001.003.505.0011.00
Book value per share (₹)271.02258.98264.48253.66225.66184.83317.50
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue232218159157204204187160
Revenue growth (YoY)+13.3%+6.8%-14.9%-1.9%+21.7%---
Other income2.644.017.360.201.070.675.042.02
Total expenses190191143136180183172158
EBITDA41.6326.4915.6221.1624.8820.7115.332.37
EBITDA margin+18.0%+12.2%+9.8%+13.5%+12.2%+10.2%+8.2%+1.5%
Depreciation10.2210.2510.119.789.429.208.998.79
Interest5.133.304.604.216.055.075.838.25
Profit before tax28.9216.958.277.3710.487.115.55(12.65)
Tax7.091.832.201.762.903.150.91(1.50)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue738719677912948574584
Revenue growth+2.7%+6.1%-25.7%-3.9%+65.2%-1.6%-
Other income12.648.258.687.803.3116.905.21
Total expenses650665638782781417410
Employee cost48.8644.9947.5041.8134.0726.6820.49
EBITDA88.2053.9739.54130167157174
EBITDA margin+12.0%+7.5%+5.8%+14.3%+17.6%+27.4%+29.8%
Depreciation39.5735.7633.9727.6327.2918.6313.04
Interest18.2024.0519.3810.546.353.491.29
Profit before tax43.072.41(5.13)99.64137152165
Tax8.715.41(2.09)24.0634.0137.4540.61
Net profit27.17(5.76)(7.58)71.88101115124
Net profit margin+3.7%-0.8%-1.1%+7.9%+10.7%+20.0%+21.2%
EPS (₹)12.26(1.07)(1.10)27.8337.9142.20102.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital28.0228.0027.5827.5627.5627.5613.98
Reserves & surplus669634637638576475374
Shareholders' funds (net worth)697662665666603502388
Secured loans216211215219270125101
Unsecured loans3.150.320.550.4435.4023.7315.29
Total debt219212216220305149117
Total liabilities936877884887909653505
Assets
Gross block912835788734605558338
Net block683644630610509478256
Capital work in progress21.1665.7086.1470.2011045.89129
Investments63.5454.0854.1752.8053.4941.9733.82
Inventories92.6288.9711411497.3466.0340.93
Sundry debtors243174209212253117111
Cash & bank balances1.637.433.576.5823.3011.7810.58
Loans & advances15.1633.6533.2731.1630.1931.1727.27
Total current assets353304360363404226190
Total current liabilities150168229186147133110
Net working capital20213613117725792.7979.47
Total assets936877884887909653505
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash7.063.216.2622.978.637.552.73
Net cash from operating activities44.2958.5685.09183(11.17)115160
Net cash from investing activities(38.90)(27.06)(65.03)(90.63)(120)(135)(191)
Net cash from financing activities(11.17)(27.65)(23.12)(109)14621.8935.43
Net change in cash(5.78)3.85(3.05)(16.70)14.341.084.82
Closing cash1.637.433.576.5823.3011.7810.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+2.7%+6.1%-25.7%-3.9%+65.2%-1.6%-
EBITDA growth+63.4%+36.5%-69.6%-22.3%+6.4%-9.4%-
PBT growth+1687.1%+9998.0%--27.3%-9.9%-7.6%-3.7%
Net income growth+571.7%+24.0%-110.6%-29.0%-11.6%-7.5%-
Revenue CAGR (3Y)-6.8%-8.8%+5.7%+16.0%+16.1%+68.2%+99.6%
EBITDA CAGR (3Y)-12.1%-31.4%-36.9%-9.2%-2.1%+81.3%+111.4%
Profitability & leverage
Net income margin+4.7%-0.4%-0.5%+8.3%+10.9%+20.0%+21.2%
Return on capital employed+6.1%+2.9%+1.0%+12.3%+18.3%+26.9%+40.5%
Return on net worth+4.0%-0.9%-1.1%+11.9%+18.6%+25.8%+38.4%
Debt / equity0.320.320.330.410.410.300.26
Long-term debt / equity0.080.090.100.120.150.180.19
Interest cover37.43132.07347.9410.294.542.520.80
Efficiency & per share
Fixed asset turnover0.850.890.891.361.631.282.17
Inventory turnover8.137.075.948.6411.6110.7414.62
Debtors turnover3.543.753.223.925.135.055.04
EPS (₹)12.26(1.07)(1.10)27.8337.9142.20102.00
Dividend per share (₹)0.000.000.001.003.505.0011.00
Book value per share (₹)248.70236.25241.12245.14221.97184.84317.50

To see the full year-wise statements and ratios of Valiant Organics Limited, buy the company report.

Board of directors of Valiant Organics Limited

Valiant Organics has 11 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sonal Amit Vira
Also directs: Valiant Laboratories Limited, Valiant Advanced Sciences Private Limited
Director04 Aug 20224 Years 2 MonthsCurrent
Navin Chapshi ShahDirector04 Aug 20224 Years 2 MonthsCurrent
Mahek Manoj Chheda
Also directs: Valiant Speciality Chemical Limited, Wearable Frameable Studio Private Limited, Gyms for All (India) Limited
Whole-Time Director06 Jul 20179 Years 3 MonthsCurrent
Nemin Mahesh SavadiaWhole-Time Director01 May 20224 Years 5 MonthsCurrent
Santosh Shantilal Vora
Also directs: Valiant Laboratories Limited, Valiant Advanced Sciences Private Limited
Director01 May 20224 Years 5 MonthsCurrent
Sathiababu Krishnan Kallada
Also directs: Valiant Speciality Chemical Limited, Shanti Intermediates Private Limited
Managing Director23 Nov 20205 Years 11 MonthsCurrent
Showing 6 of 11 current directors. View all directors

Peer comparison

Valiant Organics Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Gramercy Trade Industries Private Limited₹767.72 Cr (FY 2025)1324.0%Pune, Maharashtra, India
Eskay Iodine Private Limited₹741.41 Cr (FY 2025)33.0%Mumbai, Maharashtra, India
Valiant Organics Limitedthis company₹738.76 Cr (FY 2026)₹25.98 Cr3.5%2.8%968Mumbai, Maharashtra, India
Gulbrandsen Technologies (India) Private Limited₹738.25 Cr (FY 2024)5.0%Vadodara, Gujarat, India
Baerlocher India Additives Private Limited₹715.01 Cr (FY 2025)22.0%Mumbai, Maharashtra, India
Gargi Huttenes Albertus Private Limited₹686.13 Cr (FY 2025)7.0%Chembur Mumbai, Maharashtra, India
Yasho Industries Limited₹677.26 Cr (FY 2025)13.0%Mumbai, Maharashtra, India
Ami Lifesciences Pvt Ltd₹659.86 Cr (FY 2025)20.0%Vadodara, Gujarat, India

To see the full peer comparison of Valiant Organics Limited, buy the company report.

Auditor

Valiant Organics Limited is audited by Gokhale & Sathe for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Gokhale & SatheFY 2023103264W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 37.90%, foreign institutional investors hold 0.20%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 61.90%.

Promoters: 37.90%FII (Foreign Institutional): 0.20%Retail & Others: 61.90%
Sep 2026
QUARTER
37.90% Promoters
0.20% FII (Foreign Institutional)
61.90% Retail & Others
Promoter holding - history
Now 37.90% · Sep 2026High 37.90% · Dec 2025Low 37.90% · Dec 2025
36%36.8%37.5%38.3%39%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 37.90%Mar 2026: 37.90%Jun 2026: 37.90%Sep 2026: 37.90%37.90%37.90%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters37.90%37.90%37.90%37.90%
Public62.10%62.10%62.10%62.10%

Charges & borrowings

Open charges
₹447.5 Cr
Satisfied charges
₹294.31 Cr
Breakdown by lending institutions
The Hongkong and Shanghai Banking Corporation Limited₹180.00 Cr
Citi Bank N.A.₹122.50 Cr
Others₹115.00 Cr
Hdfc Bank Limited₹30.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
02 Jul 2026101364094Citi Bank N.A.₹50 CrOpen
24 Apr 2026101285300Others₹50 CrOpen
09 Oct 2025101172344Others₹65 CrOpen
25 Jun 2021100459191Hdfc Bank Limited₹30 CrOpen
09 Jun 2021100455267The Hongkong and Shanghai Banking Corporation Limited₹180 CrOpen

To see the full charge records of Valiant Organics Limited, buy the company report.

Total charge records: 21 View all charges

Deals & funding

Valiant Organics Limited has 27 deals on record (13 market trades, 9 secondary share transfers, 4 funding rounds), with disclosed funding of ₹10.82 Cr; the latest was in March 2026.

Total deals
27
Market trades
13
Secondary share transfers
9
Funding rounds
4
IPO
1
Disclosed funding
₹10.82 Cr

Deals on record (5 of 27)

WhenDealAmountParties
Mar 2026Market trade₹4.35 CrBuyer: NK Securities Research Private Limited
Seller: NK Securities Research Private Limited
Mar 2023Secondary share transferUndisclosedBuyer: Tulip Family Trust, 3 individuals
Seller: 4 individuals
Mar 2023Secondary share transferUndisclosedSeller: Dilesh Roadlines Private Limited , Drl Cargo Carrier Private Limited, 2 individuals
Mar 2023Market trade₹7.78 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP
Mar 2023Market trade₹7.52 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP

To see the full deal history of Valiant Organics Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Valiant Organics Limited was last rated by Crisil on 31 Dec 2020.

Rating agencyRated onRating
Crisil31 Dec 2020

To see the full credit ratings and regulatory alerts of Valiant Organics Limited, buy the company report.

MSME payment delays

Valiant Organics Limited has 4 MSME Form 1 returns on record between 2023 and 2024, listing 434 overdue payments to 127 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 127)

SupplierAmount dueDue sinceReported on
Kalpesh Roadlines Limited
an individual supplier
an individual supplier
Dhruv Agencies (Unit 2)
Cocoon Enterprise (Unit 2)

To see the full MSME payment records of Valiant Organics Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Valiant Organics has 3 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

3
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Valiant Speciality Chemical LimitedU24230GJ2019PLC111566
Valiant Advanced Sciences Private LimitedU24290MH2022PTC386388
Valiant Laboratories LimitedU24299MH2021PLC365904

To see the full group structure of Valiant Organics Limited, buy the company report.

Employees & EPFO

Valiant Organics Limited has a workforce of 968 employees on its EPFO records as of Mar 29, 2024, across 4 active EPFO establishments.

Employee count
968
Active EPFO establishments
4
Employee growth
11.65%

GST

Valiant Organics has 5 GST registrations: 3 active and 2 cancelled or inactive.

Total GSTINs
5
Active
3
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AACCV0024A2Z2MaharashtraActive13 Dec 2017
24AACCV0024A1Z9GujaratActive01 Jul 2017
24AACCV0024A2Z8GujaratActive10 Nov 2020

To see the full GST registrations and return filing status of Valiant Organics Limited, buy the company report.

Recent activity

Valiant Organics Limited has 45 board changes on record since 2005: 28 appointments and 17 cessations. The latest: Mulesh Manilal Savla ceased to be Director on 19 Apr 2025.

Charges
A charge with Hdfc Bank Limited of Rs. 30.00 Cr registered on 25 Jun 2021 with Charge ID 100459191 was modified on 21 Aug 2026.
Charges
A charge with Others of Rs. 50.00 Cr registered on 24 Apr 2026 with Charge ID 101285300 was modified on 06 Aug 2026.
Charges
A charge with Citi Bank N.A. amounted to Rs. 50.00 Cr with Charge ID 101364094 was registered on 02 Jul 2026.
Charges
A charge with Others amounted to Rs. 50.00 Cr with Charge ID 101285300 was registered on 24 Apr 2026.
Filing
Valiant Organics Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Charges
A charge with Others amounted to Rs. 65.00 Cr with Charge ID 101172344 was registered on 09 Oct 2025.
AGM
Valiant Organics Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Charges
A charge registered on 09 Dec 2020 via Charge ID 100408115 with Standard Chartered Bank was fully satisfied on 17 Sep 2025.
Charges
A charge registered on 09 Dec 2020 via Charge ID 100409963 with Citi Bank N.A. was fully satisfied on 12 Sep 2025.
Ceased
Mulesh Manilal Savla ceased to be Director.
Appointed
Paras Sumtichandra Savla was appointed as Director.
Charges
A charge registered on 09 Dec 2020 via Charge ID 100408125 with Standard Chartered Bank was fully satisfied on 17 Oct 2024.

80 earlier events are in the company report.

News

Frequently asked questions

Valiant Organics is an active public limited company based in Mumbai, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 16 February 2005 (21+ years old) and is registered under CIN L24230MH2005PLC151348. Listed on BSE: 540145 and NSE: VALIANTORG.

Valiant Organics reported revenue of ₹738.76 Cr for FY 2025-26 (up 2.8% YoY) based on consolidated financials.

Valiant Organics has 11 current directors:

The latest financial statements of Valiant Organics on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Valiant Organics is 27AACCV0024A2Z2, registered in Maharashtra. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 24AACCV0024A1Z9 (Gujarat), 24AACCV0024A2Z8 (Gujarat).

The CIN (Corporate Identification Number) of Valiant Organics is L24230MH2005PLC151348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Valiant Organics is a listed company as per MCA records. Its shares are listed on both BSE (code: 540145) and NSE (symbol: VALIANTORG).

Valiant Organics has 10 court cases on record: 3 filed by the company and 7 filed against it. 1 is pending. Most are in the district courts.

Valiant Organics was incorporated on 16 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.

Valiant Organics has 27 deals on record (13 market trades, 9 secondary share transfers, 4 funding rounds), with disclosed funding of ₹10.82 Cr; the latest was in March 2026.

The peers of Valiant Organics by revenue are Gramercy Trade Industries Private Limited, Eskay Iodine Private Limited, Gulbrandsen Technologies (India) Private Limited, Baerlocher India Additives Private Limited, Gargi Huttenes Albertus Private Limited and 2 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Mulesh Manilal Savla ceased to be Director on 19 Apr 2025. Paras Sumtichandra Savla was appointed as Director on 13 Nov 2024. Vishnu Jotiram Sawant ceased to be Whole-Time Director on 31 May 2024. Valiant Organics has 45 board changes on record in total.